Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Denosumab and Zoledronic Acid in IIMs Related Reduced Bone Mineral Density
NCT04034199Phase 3Unknown
- Sponsor
- Kwong Wah Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab, zoledronic acid in osteoporosis, osteopenia, sponsored by Kwong Wah Hospital. Status: unknown.
02
Drugs
denosumabzoledronic acid
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT04034199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034199.